世界のビソプロロール市場:成長動向・競争分析2020-2026

【英語タイトル】Global Bisoprolol Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00340)・商品コード:QYR20AP00340
・発行会社(調査会社):QYResearch
・発行日:2020年3月25日(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、ビソプロロールの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、ビソプロロールのグローバル市場動向、メーカー別競争状況、種類別市場規模(タブレット、カプセル)、用途別市場規模(高血圧(高血圧症)、冠状動脈性心臓病、狭心症、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・ビソプロロールの種類別市場2015-2026:タブレット、カプセル
・ビソプロロールの用途別市場2015-2026:高血圧(高血圧症)、冠状動脈性心臓病、狭心症、その他
・ビソプロロールの北米市場分析
・ビソプロロールのアジア市場分析
・ビソプロロールの中南米市場分析
・ビソプロロールの中東・アフリカ市場分析
・関連企業情報:Hexal (Novartis)、Merck、Teva Pharmaceuticals、Medreich、VHB Lifesciences、Shrrishti Healthcare Products、Intas Pharmaceutical、Rusan Healthcare、Vidakem Lifesciences、US Vitamins、Beijing Wellso Pharmaceutical、Yangtze River Pharmaceutical Group
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Bisoprolol is a medication most commonly used for heart diseases. This specifically includes high blood pressure, chest pain from not enough blood flow to the heart, and heart failure. It is taken by mouth.In 2019, the global Bisoprolol market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Bisoprolol.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Bisoprolol market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Bisoprolol market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Bisoprolol market. Readers of the report can become informed about current and future trends of the global Bisoprolol market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Bisoprolol markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Bisoprolol market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Bisoprolol market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Bisoprolol market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Bisoprolol market is segmented into
Tablet
Capsule

Market Segment by Application, the Bisoprolol market is segmented into
High Blood Pressure (Hypertension)
Coronary Heart Disease
Angina Pectoris
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Hexal (Novartis)
Merck
Teva Pharmaceuticals
Medreich
VHB Lifesciences
Shrrishti Healthcare Products
Intas Pharmaceutical
Rusan Healthcare
Vidakem Lifesciences
US Vitamins
Beijing Wellso Pharmaceutical
Yangtze River Pharmaceutical Group

The study objectives are:
To analyze and research the global Bisoprolol status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Bisoprolol manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bisoprolol are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Bisoprolol Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Bisoprolol Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Tablet
1.3.3 Capsule
1.4 Market Segment by Application
1.4.1 Global Bisoprolol Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 High Blood Pressure (Hypertension)
1.4.3 Coronary Heart Disease
1.4.4 Angina Pectoris
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Bisoprolol Revenue (2015-2026)
2.1.1 Global Bisoprolol Revenue (2015-2026)
2.1.2 Global Bisoprolol Sales (2015-2026)
2.2 Bisoprolol Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Bisoprolol Sales by Regions (2015-2020)
2.2.2 Global Bisoprolol Revenue by Regions (2015-2020)
2.3 Global Top Bisoprolol Regions (Countries) Ranking by Market Size
2.4 Bisoprolol Industry Trends
2.4.1 Bisoprolol Market Top Trends
2.4.2 Market Drivers
2.4.3 Bisoprolol Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Bisoprolol Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Bisoprolol Manufacturers by Sales (2015-2020)
3.1.1 Global Bisoprolol Sales by Manufacturers (2015-2020)
3.1.2 Global Bisoprolol Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Bisoprolol Sales in 2019
3.2 Global Top Manufacturers Bisoprolol by Revenue
3.2.1 Global Bisoprolol Revenue by Manufacturers (2015-2020)
3.2.2 Global Bisoprolol Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bisoprolol Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bisoprolol as of 2019)
3.4 Global Bisoprolol Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Bisoprolol Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Bisoprolol Market
3.7 Key Manufacturers Bisoprolol Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Bisoprolol Historic Market Review by Type (2015-2020)
4.1.2 Global Bisoprolol Sales Market Share by Type (2015-2020)
4.1.3 Global Bisoprolol Revenue Market Share by Type (2015-2020)
4.1.4 Bisoprolol Price by Type (2015-2020)
4.1 Global Bisoprolol Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Bisoprolol Sales Forecast by Type (2021-2026)
4.2.3 Global Bisoprolol Revenue Forecast by Type (2021-2026)
4.2.4 Bisoprolol Price Forecast by Type (2021-2026)

5 Global Bisoprolol Market Size by Application
5.1 Global Bisoprolol Historic Market Review by Application (2015-2020)
5.1.2 Global Bisoprolol Sales Market Share by Application (2015-2020)
5.1.3 Global Bisoprolol Revenue Market Share by Application (2015-2020)
5.1.4 Bisoprolol Price by Application (2015-2020)
5.2 Global Bisoprolol Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Bisoprolol Sales Forecast by Application (2021-2026)
5.2.3 Global Bisoprolol Revenue Forecast by Application (2021-2026)
5.2.4 Bisoprolol Price Forecast by Application (2021-2026)

6 North America
6.1 North America Bisoprolol Breakdown Data by Company
6.2 North America Bisoprolol Breakdown Data by Type
6.3 North America Bisoprolol Breakdown Data by Application
6.4 North America Bisoprolol Breakdown Data by Countries
6.4.1 North America Bisoprolol Sales by Countries
6.4.2 North America Bisoprolol Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Bisoprolol Breakdown Data by Company
7.2 Europe Bisoprolol Breakdown Data by Type
7.3 Europe Bisoprolol Breakdown Data by Application
7.4 Europe Bisoprolol Breakdown Data by Countries
7.4.1 Europe Bisoprolol Sales by Countries
7.4.2 Europe Bisoprolol Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Bisoprolol Breakdown Data by Company
8.2 Asia Pacific Bisoprolol Breakdown Data by Type
8.3 Asia Pacific Bisoprolol Breakdown Data by Application
8.4 Asia Pacific Bisoprolol Breakdown Data by Regions
8.4.1 Asia Pacific Bisoprolol Sales by Regions
8.4.2 Asia Pacific Bisoprolol Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Bisoprolol Breakdown Data by Company
9.2 Latin America Bisoprolol Breakdown Data by Type
9.3 Latin America Bisoprolol Breakdown Data by Application
9.4 Latin America Bisoprolol Breakdown Data by Countries
9.4.1 Latin America Bisoprolol Sales by Countries
9.4.2 Latin America Bisoprolol Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Bisoprolol Breakdown Data by Type
10.2 Middle East and Africa Bisoprolol Breakdown Data by Application
10.3 Middle East and Africa Bisoprolol Breakdown Data by Countries
10.3.1 Middle East and Africa Bisoprolol Sales by Countries
10.3.2 Middle East and Africa Bisoprolol Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Hexal (Novartis)
11.1.1 Hexal (Novartis) Corporation Information
11.1.2 Hexal (Novartis) Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Hexal (Novartis) Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Hexal (Novartis) Bisoprolol Products and Services
11.1.5 Hexal (Novartis) SWOT Analysis
11.1.6 Hexal (Novartis) Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Merck Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Merck Bisoprolol Products and Services
11.2.5 Merck SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Corporation Information
11.3.2 Teva Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Teva Pharmaceuticals Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Teva Pharmaceuticals Bisoprolol Products and Services
11.3.5 Teva Pharmaceuticals SWOT Analysis
11.3.6 Teva Pharmaceuticals Recent Developments
11.4 Medreich
11.4.1 Medreich Corporation Information
11.4.2 Medreich Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Medreich Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Medreich Bisoprolol Products and Services
11.4.5 Medreich SWOT Analysis
11.4.6 Medreich Recent Developments
11.5 VHB Lifesciences
11.5.1 VHB Lifesciences Corporation Information
11.5.2 VHB Lifesciences Business Overview and Total Revenue (2019 VS 2018)
11.5.3 VHB Lifesciences Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 VHB Lifesciences Bisoprolol Products and Services
11.5.5 VHB Lifesciences SWOT Analysis
11.5.6 VHB Lifesciences Recent Developments
11.6 Shrrishti Healthcare Products
11.6.1 Shrrishti Healthcare Products Corporation Information
11.6.2 Shrrishti Healthcare Products Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Shrrishti Healthcare Products Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Shrrishti Healthcare Products Bisoprolol Products and Services
11.6.5 Shrrishti Healthcare Products SWOT Analysis
11.6.6 Shrrishti Healthcare Products Recent Developments
11.7 Intas Pharmaceutical
11.7.1 Intas Pharmaceutical Corporation Information
11.7.2 Intas Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Intas Pharmaceutical Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Intas Pharmaceutical Bisoprolol Products and Services
11.7.5 Intas Pharmaceutical SWOT Analysis
11.7.6 Intas Pharmaceutical Recent Developments
11.8 Rusan Healthcare
11.8.1 Rusan Healthcare Corporation Information
11.8.2 Rusan Healthcare Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Rusan Healthcare Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Rusan Healthcare Bisoprolol Products and Services
11.8.5 Rusan Healthcare SWOT Analysis
11.8.6 Rusan Healthcare Recent Developments
11.9 Vidakem Lifesciences
11.9.1 Vidakem Lifesciences Corporation Information
11.9.2 Vidakem Lifesciences Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Vidakem Lifesciences Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Vidakem Lifesciences Bisoprolol Products and Services
11.9.5 Vidakem Lifesciences SWOT Analysis
11.9.6 Vidakem Lifesciences Recent Developments
11.10 US Vitamins
11.10.1 US Vitamins Corporation Information
11.10.2 US Vitamins Business Overview and Total Revenue (2019 VS 2018)
11.10.3 US Vitamins Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 US Vitamins Bisoprolol Products and Services
11.10.5 US Vitamins SWOT Analysis
11.10.6 US Vitamins Recent Developments
11.11 Beijing Wellso Pharmaceutical
11.11.1 Beijing Wellso Pharmaceutical Corporation Information
11.11.2 Beijing Wellso Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Beijing Wellso Pharmaceutical Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Beijing Wellso Pharmaceutical Bisoprolol Products and Services
11.11.5 Beijing Wellso Pharmaceutical SWOT Analysis
11.11.6 Beijing Wellso Pharmaceutical Recent Developments
11.12 Yangtze River Pharmaceutical Group
11.12.1 Yangtze River Pharmaceutical Group Corporation Information
11.12.2 Yangtze River Pharmaceutical Group Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Yangtze River Pharmaceutical Group Bisoprolol Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Yangtze River Pharmaceutical Group Bisoprolol Products and Services
11.12.5 Yangtze River Pharmaceutical Group SWOT Analysis
11.12.6 Yangtze River Pharmaceutical Group Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Bisoprolol Sales Channels
12.2.2 Bisoprolol Distributors
12.3 Bisoprolol Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Bisoprolol Sales Forecast (2021-2026)
13.1.1 Global Bisoprolol Sales Forecast by Regions (2021-2026)
13.1.2 Global Bisoprolol Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Bisoprolol Sales Forecast (2021-2026)
13.2.2 North America Bisoprolol Revenue Forecast (2021-2026)
13.2.3 North America Bisoprolol Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Bisoprolol Sales Forecast (2021-2026)
13.3.2 Europe Bisoprolol Revenue Forecast (2021-2026)
13.3.3 Europe Bisoprolol Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Bisoprolol Sales Forecast (2021-2026)
13.4.2 Asia Pacific Bisoprolol Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Bisoprolol Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Bisoprolol Sales Forecast (2021-2026)
13.5.2 Latin America Bisoprolol Revenue Forecast (2021-2026)
13.5.3 Latin America Bisoprolol Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Bisoprolol Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Bisoprolol Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Bisoprolol Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Bisoprolol Key Market Segments
Table 2. Ranking of Global Top Bisoprolol Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bisoprolol Market Size Growth Rate by Type 2021-2026 (M Doses) & (Million US$)
Table 4. Major Manufacturers of Tablet
Table 5. Major Manufacturers of Capsule
Table 6. Global Bisoprolol Market Share by Application 2019-2025 (M Doses)
Table 7. Global Bisoprolol Market Size by Regions 2015-2020 (M Doses) & (Million US$)
Table 8. Global Bisoprolol Sales by Regions 2015-2020 (M Doses)
Table 9. Global Bisoprolol Sales Market Share by Regions 2015-2020
Table 10. Global Bisoprolol Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Bisoprolol Revenue Market Share by Regions 2015-2020
Table 12. Top Bisoprolol Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Bisoprolol Key Drivers: Impact Analysis (2021-2026)
Table 15. Bisoprolol Key Challenges
Table 16. Main Points Interviewed from Key Bisoprolol Players: Views for Future
Table 17. Global Bisoprolol Sales by Manufacturers (2015-2020) (M Doses)
Table 18. Global Bisoprolol Sales Share by Manufacturers (2015-2020)
Table 19. Bisoprolol Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Bisoprolol Revenue Share by Manufacturers (2015-2020)
Table 21. Global Bisoprolol Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bisoprolol as of 2019)
Table 23. Key Manufacturers Bisoprolol Average Selling Price (ASP) (2015-2020) (USD/K Doses)
Table 24. Key Manufacturers Bisoprolol Plants/Factories Distribution
Table 25. Key Manufacturers Bisoprolol Area Served
Table 26. Date of Key Manufacturers Enter into Bisoprolol Market
Table 27. Key Manufacturers Bisoprolol Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Tablet Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 30. Global Capsule Sales and Revenue (2015-2020) (M Doses) & (Million US$)
Table 31. Global Bisoprolol Sales (M Doses) by Type (2015-2020)
Table 32. Global Bisoprolol Sales Share by Type (2015-2020)
Table 33. Global Bisoprolol Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Bisoprolol Price (M Doses) by Type (2015-2020)
Table 35. Global Bisoprolol Sales (M Doses) by Type (2021-2026)
Table 36. Global Bisoprolol Sales Share by Type (2021-2026)
Table 37. Global Bisoprolol Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Bisoprolol Revenue Share by Type (2021-2026)
Table 39. Global Bisoprolol Price (M Doses) by Type (2021-2026)
Table 40. Global Bisoprolol Sales (M Doses) by Application (2015-2020)
Table 41. Global Bisoprolol Sales Share by Application (2015-2020)
Table 42. Global Bisoprolol Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Bisoprolol Price by Application 2015-2020 (USD/K Doses)
Table 44. Global Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 45. Global Bisoprolol Sales Share by Application (2015-2020)
Table 46. Global Bisoprolol Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Bisoprolol Revenue Share by Application (2021-2026)
Table 48. Global Bisoprolol Price (M Doses) by Application (2021-2026)
Table 49. North America Bisoprolol Sales by Company (2015-2020) (M Doses)
Table 50. North America Bisoprolol Sales Market Share by Company (2015-2020)
Table 51. North America Bisoprolol Sales by Type (2015-2020) (M Doses)
Table 52. North America Bisoprolol Sales Market Share by Type (2015-2020)
Table 53. North America Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 54. North America Bisoprolol Sales Market Share by Application (2015-2020)
Table 55. North America Bisoprolol Sales by Countries (2015-2020) (M Doses)
Table 56. North America Bisoprolol Sales Market Share by Countries (2015-2020)
Table 57. North America Bisoprolol Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Bisoprolol Revenue Market Share by Countries (2015-2020)
Table 59. Europe Bisoprolol Sales by Company (2015-2020) (M Doses)
Table 60. Europe Bisoprolol Sales Market Share by Company (2015-2020)
Table 61. Europe Bisoprolol Sales by Type (2015-2020) (M Doses)
Table 62. Europe Bisoprolol Sales Market Share by Type (2015-2020)
Table 63. Europe Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 64. Europe Bisoprolol Sales Market Share by Application (2015-2020)
Table 65. Europe Bisoprolol Sales by Countries (2015-2020) (M Doses)
Table 66. Europe Bisoprolol Sales Market Share by Countries (2015-2020)
Table 67. Europe Bisoprolol Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Bisoprolol Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Bisoprolol Sales by Regions (2015-2020) (M Doses)
Table 70. Asia Pacific Bisoprolol Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Bisoprolol Sales by Type (2015-2020) (M Doses)
Table 72. Asia Pacific Bisoprolol Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 74. Asia Pacific Bisoprolol Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Bisoprolol Sales by Countries (2015-2020) (M Doses)
Table 76. Asia Pacific Bisoprolol Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Bisoprolol Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Bisoprolol Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Bisoprolol Sales by Company (2015-2020) (M Doses)
Table 80. Latin America Bisoprolol Sales Market Share by Company (2015-2020)
Table 81. Latin America Bisoprolol Sales by Type (2015-2020) (M Doses)
Table 82. Latin America Bisoprolol Sales Market Share by Type (2015-2020)
Table 83. Latin America Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 84. Latin America Bisoprolol Sales Market Share by Application (2015-2020)
Table 85. Latin America Bisoprolol Sales by Countries (2015-2020) (M Doses)
Table 86. Latin America Bisoprolol Sales Market Share by Countries (2015-2020)
Table 87. Latin America Bisoprolol Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Bisoprolol Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Bisoprolol Sales by Type (2015-2020) (M Doses)
Table 90. Middle East and Africa Bisoprolol Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Bisoprolol Sales by Application (2015-2020) (M Doses)
Table 92. Middle East and Africa Bisoprolol Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Bisoprolol Sales by Countries (2015-2020) (M Doses)
Table 94. Middle East and Africa Bisoprolol Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Bisoprolol Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Bisoprolol Revenue Market Share by Countries (2015-2020)
Table 97. Hexal (Novartis) Company Details
Table 98. Hexal (Novartis) Description and Business Overview
Table 99. Hexal (Novartis) Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 100. Hexal (Novartis) Bisoprolol Sales Growth Rate (2015-2020)
Table 101. Hexal (Novartis) Bisoprolol Sales Market Share in Global Market
Table 102. Hexal (Novartis) Recent Development
Table 103. Merck Company Details
Table 104. Merck Description and Business Overview
Table 105. Merck Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 106. Merck Bisoprolol Sales Growth Rate (2015-2020)
Table 107. Merck Bisoprolol Sales Market Share in Global Market
Table 108. Merck Recent Development
Table 109. Teva Pharmaceuticals Company Details
Table 110. Teva Pharmaceuticals Description and Business Overview
Table 111. Teva Pharmaceuticals Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 112. Teva Pharmaceuticals Bisoprolol Sales Growth Rate (2015-2020)
Table 113. Teva Pharmaceuticals Bisoprolol Sales Market Share in Global Market
Table 114. Teva Pharmaceuticals Recent Development
Table 115. Medreich Company Details
Table 116. Medreich Description and Business Overview
Table 117. Medreich Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 118. Medreich Bisoprolol Sales Growth Rate (2015-2020)
Table 119. Medreich Bisoprolol Sales Market Share in Global Market
Table 120. Medreich Recent Development
Table 121. VHB Lifesciences Company Details
Table 122. VHB Lifesciences Description and Business Overview
Table 123. VHB Lifesciences Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 124. VHB Lifesciences Bisoprolol Sales Growth Rate (2015-2020)
Table 125. VHB Lifesciences Bisoprolol Sales Market Share in Global Market
Table 126. VHB Lifesciences Recent Development
Table 127. Shrrishti Healthcare Products Company Details
Table 128. Shrrishti Healthcare Products Description and Business Overview
Table 129. Shrrishti Healthcare Products Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 130. Shrrishti Healthcare Products Bisoprolol Sales Growth Rate (2015-2020)
Table 131. Shrrishti Healthcare Products Bisoprolol Sales Market Share in Global Market
Table 132. Shrrishti Healthcare Products Recent Development
Table 133. Intas Pharmaceutical Company Details
Table 134. Intas Pharmaceutical Description and Business Overview
Table 135. Intas Pharmaceutical Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 136. Intas Pharmaceutical Bisoprolol Sales Growth Rate (2015-2020)
Table 137. Intas Pharmaceutical Bisoprolol Sales Market Share in Global Market
Table 138. Intas Pharmaceutical Recent Development
Table 139. Rusan Healthcare Company Details
Table 140. Rusan Healthcare Description and Business Overview
Table 141. Rusan Healthcare Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 142. Rusan Healthcare Bisoprolol Sales Growth Rate (2015-2020)
Table 143. Rusan Healthcare Bisoprolol Sales Market Share in Global Market
Table 144. Rusan Healthcare Recent Development
Table 145. Vidakem Lifesciences Company Details
Table 146. Vidakem Lifesciences Description and Business Overview
Table 147. Vidakem Lifesciences Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 148. Vidakem Lifesciences Bisoprolol Sales Growth Rate (2015-2020)
Table 149. Vidakem Lifesciences Bisoprolol Sales Market Share in Global Market
Table 150. Vidakem Lifesciences Recent Development
Table 151. US Vitamins Company Details
Table 152. US Vitamins Description and Business Overview
Table 153. US Vitamins Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 154. US Vitamins Bisoprolol Sales Growth Rate (2015-2020)
Table 155. US Vitamins Bisoprolol Sales Market Share in Global Market
Table 156. US Vitamins Recent Development
Table 157. Beijing Wellso Pharmaceutical Company Details
Table 158. Beijing Wellso Pharmaceutical Description and Business Overview
Table 159. Beijing Wellso Pharmaceutical Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 160. Beijing Wellso Pharmaceutical Bisoprolol Sales Growth Rate (2015-2020)
Table 161. Beijing Wellso Pharmaceutical Bisoprolol Sales Market Share in Global Market
Table 162. Beijing Wellso Pharmaceutical Recent Development
Table 163. Yangtze River Pharmaceutical Group Company Details
Table 164. Yangtze River Pharmaceutical Group Description and Business Overview
Table 165. Yangtze River Pharmaceutical Group Bisoprolol Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 166. Yangtze River Pharmaceutical Group Bisoprolol Sales Growth Rate (2015-2020)
Table 167. Yangtze River Pharmaceutical Group Bisoprolol Sales Market Share in Global Market
Table 168. Yangtze River Pharmaceutical Group Recent Development
Table 169. Bisoprolol Distributors List
Table 170. Bisoprolol Customers List
Table 171. Global Bisoprolol Sales Forecast 2021-2026 (M Doses) & (Million US$)
Table 172. Global Bisoprolol Sales Forecast by Type 2021-2026 (M Doses)
Table 173. Global Bisoprolol Sales Forecast by Application 2021-2026 (M Doses)
Table 174. Global Bisoprolol Sales Forecast by Regions 2021-2026 (M Doses)
Table 175. Global Bisoprolol Revenue Forecast by Regions 2021-2026 (Million US$)
Table 176. North America Bisoprolol Sales Forecast by Countries 2021-2026 (M Doses)
Table 177. North America Bisoprolol Revenue Forecast by Countries 2021-2026
Table 178. Europe Bisoprolol Sales Forecast by Countries 2021-2026 (M Doses)
Table 179. Europe Bisoprolol Revenue Market Share Forecast by Countries 2021-2026
Table 180. Asia Pacific Bisoprolol Sales Forecast by Regions 2021-2026 (M Doses)
Table 181. Asia Pacific Bisoprolol Revenue Forecast by Regions 2021-2026 (Million US$)
Table 182. Latin America Bisoprolol Sales Forecast by Countries 2021-2026 (M Doses)
Table 183. Latin America Bisoprolol Revenue Forecast by Countries 2021-2026 (Million US$)
Table 184. Middle East and Africa Bisoprolol Sales Forecast by Regions 2021-2026 (M Doses)
Table 185. Middle East and Africa Bisoprolol Revenue Forecast by Regions 2021-2026 (Million US$)
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Bisoprolol Product Picture
Figure 2. Global Bisoprolol Sales Market Shar by Type 2015-2026
Figure 3. Tablet Figures
Figure 4. Capsule Figures
Figure 5. Global Bisoprolol Sales Market Share by Application in 2019 & 2026
Figure 6. High Blood Pressure (Hypertension) Use Case
Figure 7. Coronary Heart Disease Use Case
Figure 8. Angina Pectoris Use Case
Figure 9. Others Use Case
Figure 10. Bisoprolol Report Years Considered
Figure 11. Global Bisoprolol Market Size 2015-2026 (Million US$)
Figure 12. Global Bisoprolol Sales 2015-2020 (M Doses)
Figure 13. Global Bisoprolol Market Size Market Share by Regions 2015-2020
Figure 14. Global Bisoprolol Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Bisoprolol Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Bisoprolol Sales in 2019
Figure 18. Bisoprolol Value Share by Manufacturers in 2019
Figure 19. Bisoprolol Revenue Share by Manufacturers In 2019
Figure 20. Bisoprolol Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Bisoprolol Revenue Share by Type (2015-2020)
Figure 22. Global Bisoprolol Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Bisoprolol Market Share by Price Range (2015-2020)
Figure 24. Global Bisoprolol Revenue Share by Application (2015-2020)
Figure 25. Global Bisoprolol Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Bisoprolol Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 28. Canada Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 29. Europe Bisoprolol Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 31. France Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 32. U.K. Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 33. Italy Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 34. Russia Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Asia Pacific Bisoprolol Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 37. Japan Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 38. South Korea Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 39. India Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Australia Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 41. Taiwan Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 42. Indonesia Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Thailand Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 44. Malaysia Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 45. Philippines Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 46. Vietnam Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 47. Latin America Bisoprolol Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Brazil Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 50. Argentina Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Middle East and Africa Bisoprolol Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 53. Saudi Arabia Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 54. U.A.E Bisoprolol Sales Growth Rate (2015-2020) (M Doses)
Figure 55. Hexal (Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Medreich Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. VHB Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Shrrishti Healthcare Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Intas Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Rusan Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Vidakem Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. US Vitamins Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Beijing Wellso Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Yangtze River Pharmaceutical Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Bisoprolol Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Bisoprolol Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 71. North America Bisoprolol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Europe Bisoprolol Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 73. Europe Bisoprolol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Asia Pacific Bisoprolol Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 75. Asia Pacific Bisoprolol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Latin America Bisoprolol Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 77. Latin America Bisoprolol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Middle East and Africa Bisoprolol Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 79. Middle East and Africa Bisoprolol Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed


【掲載企業】

Hexal (Novartis)、Merck、Teva Pharmaceuticals、Medreich、VHB Lifesciences、Shrrishti Healthcare Products、Intas Pharmaceutical、Rusan Healthcare、Vidakem Lifesciences、US Vitamins、Beijing Wellso Pharmaceutical、Yangtze River Pharmaceutical Group

★調査レポート[世界のビソプロロール市場:成長動向・競争分析2020-2026] (コード:QYR20AP00340)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のビソプロロール市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆